These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 115017)

  • 41. Comparison between EEG and observation of rabbit behaviour in evaluation of subarachnoid neurotoxicity of metrizamide.
    Maly P; Elmqvist D; Almén T; Golman K
    Acta Radiol Diagn (Stockh); 1986; 27(2):235-40. PubMed ID: 3716871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.
    Corne SJ; Pickering RW
    Psychopharmacologia; 1967; 11(1):65-78. PubMed ID: 5302272
    [No Abstract]   [Full Text] [Related]  

  • 43. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 44. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurobehavioral toxicology of trialkyltins.
    McMillan DE; Wenger GR
    Pharmacol Rev; 1985 Dec; 37(4):365-79. PubMed ID: 2872688
    [No Abstract]   [Full Text] [Related]  

  • 46. Psilocin: effects on behaviour and brain serotonin in mice.
    Collins RL; Ordy JM; Samorajski T
    Nature; 1966 Feb; 209(5025):785-7. PubMed ID: 5922147
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs.
    Canon JG; Lippa AS
    Pharmacol Biochem Behav; 1977 May; 6(5):591-3. PubMed ID: 19772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavioral analysis of diazepam-induced memory deficits: evidence for sedation-like effects.
    Kalynchuk LE; Beck CH
    Psychopharmacology (Berl); 1992; 106(3):297-302. PubMed ID: 1570374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute reactions to drugs of abuse.
    Med Lett Drugs Ther; 1996 May; 38(974):43-6. PubMed ID: 8628181
    [No Abstract]   [Full Text] [Related]  

  • 50. Hallucinatory behaviors in primates produced by around-the-clock amphetamine treatment for several days via implanted capsules.
    Nielsen EB; Eison MS; Lyon M; Iversen SD
    Prog Clin Biol Res; 1983; 131():79-100. PubMed ID: 6417669
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal.
    Andreatini R; Leite JR
    Eur J Pharmacol; 1994 Aug; 260(2-3):233-5. PubMed ID: 7988648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationships among hallucinogenic tryptamine derivatives evaluated by schedule-controlled behaviour.
    Harris RA; Homfeld E; Campaigne E
    J Pharm Pharmacol; 1981 May; 33(5):320-2. PubMed ID: 6116783
    [No Abstract]   [Full Text] [Related]  

  • 53. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central effects of three fluorinated benzodiazepines in comparison with diazepam.
    Babbini M; Torrielli MV; Gaiardi M; Bartoletti M; De Marchi F
    Pharmacology; 1974; 12(2):74-83. PubMed ID: 4431836
    [No Abstract]   [Full Text] [Related]  

  • 55. The influence of anticholinergic hallucinogens on spontaneous and conditioned behaviour in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(3):195-6. PubMed ID: 5113839
    [No Abstract]   [Full Text] [Related]  

  • 56. Behavioural changes in primates and diazepam metabolism.
    Coutinho CB; Cheripko JA; Carbone JJ; Manning JE; Boff E
    Xenobiotica; 1973 Oct; 3(10):681-90. PubMed ID: 4204374
    [No Abstract]   [Full Text] [Related]  

  • 57. 3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.
    Kirkpatrick WE; Okabe T; Hillyard IW; Robins RK; Dren AT; Novinson T
    J Med Chem; 1977 Mar; 20(3):386-93. PubMed ID: 15111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat.
    Commissaris RL; Rech RH
    Psychopharmacology (Berl); 1982; 76(3):282-5. PubMed ID: 6808551
    [No Abstract]   [Full Text] [Related]  

  • 59. Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines.
    Curry SH; Whelpton R; Nicholson AN; Wright CM
    Br J Pharmacol; 1977 Nov; 61(3):325-30. PubMed ID: 412540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative effect of central nervous system acting drugs on the open field performance in rats.
    Dandiya PC; Gupta BD; Gupta ML
    Indian J Med Res; 1970 Apr; 58(4):487-94. PubMed ID: 4394194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.